abstract |
The present invention relates to antisense oligonucleotides and/ or compounds that modulate the expression of and/or function of Filaggrin (FLG), in particular, by targeting natural antisense polynucleotides of Filaggrin (FLG). The invention also relates to the identification of these antisense oligonucleotides and/ or compounds and their use in treating diseases and disorders associated with the expression of FLG. |